Pharmacogenomic testing for antidepressant selection (2:40), lung cancer screening (4:00), temporomandibular disorders (8:50), SGLT-2 inhibitors for heart failure (13:00), analgesics in soft tissue injury (15:00), and tonsillitis (17:30).
